Association of Central Blood Pressure and Carotid Intima Media Thickness with New-Onset Hypertension in People with High Normal Blood Pressure.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 5 12 2023
pubmed: 6 7 2023
entrez: 5 7 2023
Statut: ppublish

Résumé

People with high normal blood pressure (BP) have a higher risk of cardiovascular events than those with normal BP; therefore, progression to hypertension (HT) should be prevented. We aimed to assess the HT risk using central BP and carotid intima media thickness (CIMT) in people with high normal BP. This prospective cohort study used the Tohoku Medical Megabank Community-Based Project Cohort Study (conducted from 2013 in Miyagi Prefecture in Japan). The participants had a high normal BP, defined as a systolic BP of 120-139 mmHg and diastolic BP <90 mmHg using brachial BP measurement during the baseline survey. The outcome was new-onset HT during the secondary survey, conducted four years after the baseline survey. Overall, 4,021 participants with high normal BP during the baseline survey, with an average age of 58.7 years, were included; 1,030 (26%) were diagnosed with new-onset HT during the secondary survey, 3.5±0.7 years after the baseline survey. The multivariable odds ratio (95% confidence interval) for HT in the highest versus lowest quartile of central BP was 1.7 (1.2-2.4, p=0.0030), and that of CIMT was 1.8 (1.4-2.4, p<0.001). Subgroup analysis according to age (<60 and ≥ 60 years) and sex revealed that the central BP was influential in groups with younger age and female individuals; CIMT was influential in all groups. Higher central BP and thicker CIMT at the baseline were correlated with new-onset HT in individuals with high normal BP, independent of brachial systolic BP and other cardiovascular risk factors.

Identifiants

pubmed: 37407442
doi: 10.5551/jat.64151
pmc: PMC10703569
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1905-1916

Références

Am J Epidemiol. 2002 Jan 1;155(1):38-47
pubmed: 11772783
Clin Exp Hypertens. 2021 Oct 03;43(7):610-621
pubmed: 34229544
J Epidemiol. 2021 Jan 5;31(1):65-76
pubmed: 31932529
Chest. 1992 Oct;102(4):1193-8
pubmed: 1395767
J Clin Hypertens (Greenwich). 2020 Nov;22(11):2004-2013
pubmed: 32966692
J Clin Ultrasound. 2013 Jul-Aug;41(6):333-9
pubmed: 23553729
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
Hypertension. 2012 Feb;59(2):219-25
pubmed: 22203738
J Hypertens. 2009 Mar;27(3):461-7
pubmed: 19330899
Vasc Med. 2000;5(3):141-5
pubmed: 11104296
Kardiol Pol. 2019;77(2):71-159
pubmed: 30816983
J Med Invest. 2015;62(3-4):126-9
pubmed: 26399335
Circulation. 2020 Aug 18;142(7):621-642
pubmed: 32546049
Diabetol Int. 2020 Jul 24;11(3):165-223
pubmed: 32802702
Br J Anaesth. 2004 May;92(5):651-7
pubmed: 15003985
Atherosclerosis. 2005 Apr;179(2):325-31
pubmed: 15777549
J Hypertens. 2007 Feb;25(2):265-72
pubmed: 17211229
Eur J Prev Cardiol. 2016 Jan;23(2):194-205
pubmed: 25416041
Am J Hypertens. 2009 Mar;22(3):267-72
pubmed: 19039309
Circulation. 2007 Jan 30;115(4):459-67
pubmed: 17242284
Hypertension. 2005 Jul;46(1):221-6
pubmed: 15867140
Hypertens Res. 2020 Jan;43(1):62-71
pubmed: 31562419
Eur Heart J. 2007 Feb;28(4):398-406
pubmed: 17277033
Hypertens Res. 2021 Jul;44(7):858-865
pubmed: 33589797
Hypertens Res. 2022 May;45(5):866-875
pubmed: 35043014
Hypertension. 2020 Jun;75(6):1334-1357
pubmed: 32370572
Cochrane Database Syst Rev. 2017 Apr 09;4:CD004022
pubmed: 28391629
Biomed Pharmacother. 2005 Oct;59 Suppl 1:S49-53
pubmed: 16275507
Medicine (Baltimore). 2018 Sep;97(38):e12450
pubmed: 30235731
Patient Prefer Adherence. 2020 Oct 12;14:1863-1872
pubmed: 33116431
Curr Hypertens Rev. 2012 May;8(2):80-90
pubmed: 22866025
Eur Heart J. 2014 Jul;35(26):1719-25
pubmed: 24459197
N Engl J Med. 1994 May 19;330(20):1431-8
pubmed: 8159199
Eur Heart J. 2014 Nov 21;35(44):3122-33
pubmed: 25112663
Eur Heart J. 2010 Aug;31(15):1865-71
pubmed: 20197424
Hypertens Res. 2012 Sep;35(9):947-53
pubmed: 22739419
Ann Med. 2022 Dec;54(1):1-10
pubmed: 34935572
J Physiol. 2000 May 15;525 Pt 1:263-70
pubmed: 10811742
Am J Hypertens. 2021 Sep 22;34(9):915-918
pubmed: 33904901
Am J Epidemiol. 1997 Sep 15;146(6):483-94
pubmed: 9290509
Hypertension. 2008 Jun;51(6):1476-82
pubmed: 18426997
Hypertens Res. 2019 Sep;42(9):1235-1481
pubmed: 31375757
Arterioscler Thromb. 1991 Sep-Oct;11(5):1245-9
pubmed: 1911709
Stroke. 2004 Dec;35(12):2788-94
pubmed: 15528460
Circulation. 2010 Feb 2;121(4):505-11
pubmed: 20083680
Hypertens Res. 2016 May;39(5):362-6
pubmed: 26791011

Auteurs

Sayuri Tokioka (S)

Tohoku University Graduate School of Medicine.

Naoki Nakaya (N)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Kumi Nakaya (K)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Masato Takase (M)

Tohoku University Graduate School of Medicine.

Mana Kogure (M)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Rieko Hatanaka (R)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Ippei Chiba (I)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Ikumi Kanno (I)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Kotaro Nochioka (K)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.

Hirohito Metoki (H)

Tohoku Medical Megabank Organization, Tohoku University.
Tohoku Medical and Pharmaceutical University.

Takahisa Murakami (T)

Tohoku Medical Megabank Organization, Tohoku University.
Tohoku Medical and Pharmaceutical University.

Michihiro Satoh (M)

Tohoku Medical Megabank Organization, Tohoku University.
Tohoku Medical and Pharmaceutical University.

Tomohiro Nakamura (T)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Taku Obara (T)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.

Yohei Hamanaka (Y)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Tomoko Kobayashi (T)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.

Akira Uruno (A)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Junichi Sugawara (J)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.
Suzuki Memorial Hospital.

Eiichi N Kodama (E)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.

Soichi Ogishima (S)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Yoko Izumi (Y)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Nobuo Fuse (N)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
Tohoku University Hospital, Tohoku University.

Shinichi Kuriyama (S)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.
International Research Institute of Disaster Science, Tohoku University.

Ichiro Tsuji (I)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Atsushi Hozawa (A)

Tohoku University Graduate School of Medicine.
Tohoku Medical Megabank Organization, Tohoku University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH